Similarly, the search for mutations inactivating the p53 tumor suppressor gene revealed that this event was rare in CML-BC, as one out of twenty (5%) CML-BC patients harbored p53 mutation [401]. The gene discussed is TP53; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.